Status:
NOT_YET_RECRUITING
An Open-Label Pilot Study of Qualia Senolytic Supplementation for the Attenuation of Systemic Inflammatory Cytokines
Lead Sponsor:
Qualia Life Sciences
Conditions:
Inflammation
Eligibility:
All Genders
45-79 years
Phase:
NA
Brief Summary
This open-label pilot study includes adults aged 45 to 79 residing in the United States. The study will last 7 days. Participants will provide blood samples via an at-home finger-prick kit at baseline...
Detailed Description
Objectives Within-group changes in outcomes will be compared from baseline to the end of the study period. Primary Outcome Measures: Biomarkers in blood, measured using the Olink Target 48 Cytokine ...
Eligibility Criteria
Inclusion
- Provide voluntary, written, informed consent to participate in the study
- Agree to provide a valid cell phone number and are willing to receive communications through text.
- Healthy adults 45 - 79 years of age Can read and write English
- Willing to not begin taking any new supplements during the study and continue taking any supplements they are currently using regularly.
- Willing to self-administer the fingerstick test kit at home for both a baseline and post-intervention blood sample, and to complete a release form that gives NHC access to the results of these tests.
- Willing to complete questionnaires, records, and diaries associated with the study.
Exclusion
- Women who are pregnant, breastfeeding, or planning to become pregnant during the trial
- Known food intolerances/allergy to any ingredients in the product
- Having any of the following conditions: Psychiatric conditions, neurologic disorders, endocrine disorders, cancer
- Having had a significant cardiovascular event in the past 6 months
- Taking MAO inhibitors, SSRIs, or any other psychiatric or neurological medicines
- On immunosuppressive therapy
- Individuals who were deemed incompatible with the test protocol
- Adults lacking capacity to consent
Key Trial Info
Start Date :
May 12 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
May 18 2025
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT06953518
Start Date
May 12 2025
End Date
May 18 2025
Last Update
May 1 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Qualia Life Sciences
Carlsbad, California, United States, 92011